REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $257,000 | -32.0% | 114,400 | 0.0% | 0.00% | – |
| Q3 2016 | $378,000 | +23.9% | 114,400 | +8.3% | 0.00% | – |
| Q2 2016 | $305,000 | -59.0% | 105,600 | -1.6% | 0.00% | – |
| Q1 2016 | $744,000 | -31.9% | 107,300 | -14.4% | 0.00% | – |
| Q4 2015 | $1,093,000 | +39.6% | 125,300 | +4.7% | 0.00% | – |
| Q3 2015 | $783,000 | -39.4% | 119,700 | +1.5% | 0.00% | – |
| Q2 2015 | $1,292,000 | -21.6% | 117,900 | +21.3% | 0.00% | – |
| Q1 2015 | $1,647,000 | -28.6% | 97,200 | -71.2% | 0.00% | -100.0% |
| Q3 2014 | $2,306,000 | -14.9% | 337,567 | +0.1% | 0.00% | 0.0% |
| Q2 2014 | $2,711,000 | -10.7% | 337,159 | +0.2% | 0.00% | 0.0% |
| Q1 2014 | $3,036,000 | -39.4% | 336,599 | -50.4% | 0.00% | 0.0% |
| Q4 2013 | $5,012,000 | +99.4% | 678,230 | +154.4% | 0.00% | 0.0% |
| Q3 2013 | $2,514,000 | – | 266,590 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,039,823 | $26,420,000 | 3.79% |
| Foresite Capital Management II, LLC | 1,750,269 | $11,447,000 | 3.48% |
| ARGONAUT CAPITAL MANAGEMENT CORP | 75,000 | $491,000 | 1.65% |
| Abingworth LLP | 327,350 | $2,138,000 | 1.25% |
| Trellus Management Company, LLC | 100,000 | $654,000 | 0.96% |
| Cormorant Asset Management, LP | 896,522 | $5,863,000 | 0.94% |
| DAFNA Capital Management LLC | 90,000 | $589,000 | 0.58% |
| ORACLE INVESTMENT MANAGEMENT INC | 749,064 | $4,898,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |